#United States #LYNX #Norlase #Redwood City, California #Laser Ophthalmoscope

Norlase Introduces the World’s First Pattern Scanning Laser Indirect Ophthalmoscope

Norlase, a leader in the field of ophthalmic lasers, announced a monumental breakthrough with the launch of the LYNX™, marking the first ever laser indirect ophthalmoscope (LIO) that utilizes pattern scanning technology. This innovative device has just secured both FDA 510(k) clearance and CE marking, enabling its immediate commercial rollout. Designed for flexibility and ease of use, the LYNX™ allows ophthalmologists to perform treatments with the advanced capabilities that modern eye care requires.

A Game-Changer in Ophthalmology

The LYNX™ is battery-operated, offering an unprecedented wireless solution that enables surgeons to operate in various settings without restrictions. The integration of the laser module and pattern scanning capabilities directly into the ergonomic viewer alleviates the need for bulky external laser sources. Surgeons are now empowered to move efficiently and freely during procedures, thanks to features like an intuitive wireless user interface and multilingual voice control that streamline the treatment process.

Oliver Hvidt, CEO and co-founder of Norlase, emphasizes the project’s significance: "Today’s ophthalmologists value their time above all else. The LIO model, with pattern scanning, has been in demand since its inception over 15 years ago. With LYNX, we deliver what was long-awaited. Faster LIO treatments mean reduced ergonomic stress for doctors, allowing for more quality time spent with patients, and ensuring that workdays end on time. I’m proud of our team’s capabilities and thankful to the medical professionals who paved the way for this product development."

Positive Feedback from Early Users

Early adopters of the LYNX™ have lauded its performance, praising its innovative combination of speed and efficiency. Dr. Daniel Diaz from Retina Consultants in Miami remarked, "This device sets a new standard for indirect laser treatments, merging the high-speed efficiency of pattern scanning laser technology with unparalleled portability and comfort. It has noticeably enhanced the pace and quality of my retinal treatments."

With the introduction of LYNX™, Norlase continues its trend of innovative launches, marking it as the company’s fourth product announcement since 2019. It follows the legacy of its predecessors by remaining compact, portable, and economically viable, with the goal of making cutting-edge laser technology more accessible to ophthalmologists worldwide.

Features of LYNX™ Laser Indirect Ophthalmoscope

• - Integrated laser, scanner, and delivery system within a lightweight viewer
• - Battery-powered for unmatched portability and operational flexibility
• - A full palette of patterns from 2x2 to 5x5 grids, triple arcs, and circles
• - SimplyCLEAR safety filters for enhanced visualization
• - Multilingual voice control of patterns and parameters

About Norlase

Founded in Denmark, Norlase specializes in next-generation laser solutions aimed at treating glaucoma and retinal conditions. The company comprises leading experts in ophthalmology, laser technology, medical device development, and customer service. Norlase’s mission focuses on improving treatment efficiency, enhancing patient care, and supporting ophthalmologists worldwide. They offer several groundbreaking products, including LEAF, a laser photocoagulator significantly smaller than current models, LION, the first fully integrated green laser and LIO, ECHO, the world’s first ultraportable pattern scanning laser, and now LYNX.

For more information about Norlase and its innovative products, visit norlase.com.